COLLEGIUM PHARMACEUTICAL INC
19.1000
-1.55%
19.1000
-1.55%
9.0100 29.9000
52 weeks
52 weeks

Mkt Cap 562.66M

Shares Out 29.46M

new Chat
Send me real-time posts from this site at my email

Today is FDA action date for Collegium's Xtampza ER approval

Today is the FDA's PDUFA date for approving Collegium Pharmaceutical's (COLL -2%) NDA for lead product candidate Xtampza ER (oxycodone extended-release capsules), an abuse-deterrent oral formulation of the widely...


More
Followers
3